Compounds having Formula I
are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of treating cancer in a mammal.
The present invention relates to compounds and pharmaceutical compositions which are proteomimetic and to methods for inhibiting the interaction of an alpha-helical protein with another protein or binding site. Methods for treating diseases or conditions which are modulated through interactions between alpha helical proteins and their binding sites are other aspects of the invention.
[EN] SUBSTITUTED OXAZOLINES AS ANTIPROLIFERATIVE AGENTS<br/>[FR] ANTIPROLIFERANTS A BASE D'OXAZOLINES SUBSTITUEES
申请人:ABBOTT LAB
公开号:WO2000006556A1
公开(公告)日:2000-02-10
Compounds having Formula (I) are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), and methods of treating cancer in a mammal.
This invention relates to novel amide derivatives and salts thereof. More particularly, it relates to novel amide derivatives and salts thereof which act as a ROCK inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of ROCK-related disease.
This invention relates to novel amide derivatives and salts thereof. More particularly, it relates to novel amide derivatives and salts thereof which act as a ROCK inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of ROCK-related disease.